Skip to main content
GameRevenueData

Developer

StudioGIW Games: Revenue & Sales Estimates

Revenue estimates for the 8 Steam games developed by StudioGIW, ranked by estimated net revenue. Available estimated lifetime net (USD): $36.3K.

Catalog Est. Lifetime Net (USD)

$36.3K

Estimates for 5 of 8 tracked games

Tracked games

8

Top Earner

VasterClaws 3:Dragon slayer of the God world

$11.4K

Coverage: 8 tracked titles; 5 with net estimates; 3 without. 0 have dedicated profiles. Missing estimates are excluded from the aggregate, not treated as known zero revenue.

Role: Developer. These are lifetime estimates for games credited to StudioGIW; they are not company earnings, profit, or contractual receipts. Credits may omit co-development or historical publishing arrangements. Developer and publisher identities are not merged by matching names.

Recorded release dates: 2015-10-16–2023-10-26 (may include announced dates).

Largest title accounts for 31.3% of available estimated net revenue. Coverage gaps can change this share.

Showing 1–8 of the top 8 displayed entries, from 8 tracked titles. Figures include only available estimates. Search the full catalog .

Rows 1–8 · Page 1 of 1

# Game Est. lifetime net (USD) Positive reviews (raw) Release
1 VasterClaws 3:Dragon slayer of the God world $11.4K 65%Mixed (20) Mar 18, 2020
2 Dungeon Manager ZV $11.1K 68%Mixed (76) Oct 16, 2015
3 Avaris 2: The Return of the Empress $10K 58%Mixed (59) Dec 14, 2015
4 Dungeon Manager ZV: Resurrection $2K 100%Positive (10) Aug 15, 2017
5 Dungeon Manager ZV 2 $1.9K 55%Mixed (11) Feb 17, 2017
6 ALVAROK 50%Mixed (2) Nov 1, 2017
7 VAZIAL SAGA XX 80%Positive (5) Sep 2, 2021
8 AVARIS3 100%Positive (4) Oct 26, 2023

Get real-time dashboards, historical trends, and AI-powered analysis

Explore on PlayRev(opens in new tab)

Revenue and sales estimates are based on the Boxleiter method using publicly available data including Steam review counts, pricing history, and statistical modeling. Actual revenue may differ significantly. These figures are provided for informational purposes only and should not be used for financial decisions. Read the full methodology.